Efficacy of a Smartphone App. Designed to Manage Craving & Individual Predictors of Substance Use/Addictive Behavior
NCT ID: NCT04732676
Last Updated: 2025-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
274 participants
INTERVENTIONAL
2023-03-01
2028-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PHOENIX: Craving Management Smartphone Application
NCT06140472
A Electronic System to Improve Recovery Outcomes in Patients With Drug Use Disorder
NCT03451344
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
NCT00000210
Application Based Addiction Treatment Adherence Trial
NCT04680741
A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders
NCT05086835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This new therapeutic tool, designed by University of Bordeaux, Sanpsy Lab, CNRS USR3413 - to manage craving and individual predictors of use, will offer the possibility of an easy to-use and personalized intervention accessible to the greatest number of subjects.
Based on our previous results that supports that, for all types of addiction, craving and individual cues are a significant drive for use in people with addiction, the application tested in this study was designed to be used among people presenting various types of addiction (substance and behavioral addictions). The application will also evaluate all concurrent substance uses and addictive behaviors to identify and prevent risk of addiction transfers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Randomization code will unlock one of the 2 versions of the application:
* Restricted version (only EMA) for control group
* Full interventional (active) version (EMA + EMI) for experimental group
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
participants will receive and use during 4 weeks the full interventional version of the smartphone application (combining EMA + EMI) targeting craving and personal situations at risk for use
Smartphone application
Ecological Momentary Assessment (EMA)
: ambulatory assessment of behaviors/symptoms in real-time on smartphones
control group
: participants will receive and use a restricted version of the smartphone application (only EMA: 4 electronic questionnaires per day to assess main problematic substance use / addictive behavior) during 4 weeks
Smartphone application
Ecological Momentary Assessment (EMA)
: ambulatory assessment of behaviors/symptoms in real-time on smartphones
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smartphone application
Ecological Momentary Assessment (EMA)
: ambulatory assessment of behaviors/symptoms in real-time on smartphones
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>= 18 years of age
* With at least one substance or behavioral addiction (DSM-5 criteria)
* Affiliated person or beneficiary of a social security scheme.
* Free, informed and written consent signed by the participant and the investigator
Exclusion Criteria
* Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy....)
* Difficulty in understanding and / or writing French
* Not familiar with the use of smartphone
* Individuals participating in another study that includes an ongoing exclusion period
* Be deprived of liberty due to an ongoing legal procedure
* Individuals under legal protection
* Be under guardianship or under curatorship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Charles Perrens, Bordeaux
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MARC AURIACOMBE, MD, Prof
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier CHARLES PERRENS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Charles PERRENS
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Serre F, Moriceau S, Donnadieu L, Forcier C, Garnier H, Alexandre JM, Dupuy L, Philip P, Levavasseur Y, De Sevin E, Auriacombe M; for Craving-Manager RCT investigator group. The Craving-Manager smartphone app designed to diagnose substance use/addictive disorders, and manage craving and individual predictors of relapse: a study protocol for a multicenter randomized controlled trial. Front Psychiatry. 2023 May 15;14:1143167. doi: 10.3389/fpsyt.2023.1143167. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01707-32
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.